SIRT1 and acute myeloid leukemia: In a HFD-induced mouse model of MASLD and Palmitic acid (PA)-treated AML-12 cells, didymin increased SIRT1 expression and directly activated SIRT1, thereby enhancing mitochondrial biogenesis and function, reducing apoptosis, and promoting lipophagy, ultimately alleviating MASLD51.